-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Objective : Cartilage oligomeric matrix protein (COMP) is an autoantigen in rheumatoid arthritis (RA) and experimental models of arthriti.
Objective Cartilage oligomeric matrix protein (COMP) is an autoantigen in rheumatoid arthritis (RA) and experimental models of arthriti.
Methods We investigated the pathogenicity of monoclonal anti- COMP antibodies in mice using passive transfer experiments and explored the interaction of anti- immune COMP antibodies with cartilage using immunohistochemical stainin.
Results The murine monoclonal anti- COMP antibody 15A11 induced arthritis in naive mi.
Conclusions The findings provide a structural basis for binding pathogenic anti- COMP antibodies to cartila.
Source: Ge,.
Ge,.
, Tong,.
, Lönnblom,.
, Liang,.
, Cai,.
, Fahlquist-Hagert,.
, Li,.
, Kastbom,.
, Gjertsson,.
, Dobritzsch, .
and Holmdahl,.
(2022), Antibodies to Cartilage Oligomeric Matrix Protein Are Pathogenic in Mice and May Be Clinically Relevant in Rheumatoid Arthrit.
Arthritis Rheumatol, 74: 961-97https://d.
org/11002/a.
42072 https://d.
org/11002/a.
42072 Leave a comment here